Phase 3 Neuroblastoma Trial With hu14 Antibody
Summary
A Phase 3 clinical trial evaluating hu14 antibody for neuroblastoma has been registered on ClinicalTrials.gov. The trial is listed as recruiting participants and includes standard registry information on study design and eligibility criteria. This entry provides public visibility into ongoing late-stage oncology research.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 12 changes logged to date.
What changed
A new Phase 3 clinical trial for neuroblastoma using the hu14 antibody has been registered on ClinicalTrials.gov. The registry entry contains standard trial metadata including NCT number NCT07549321, phase classification, and recruitment status.
Affected parties include clinical investigators, oncology research institutions, and patients seeking late-stage clinical trial options. The entry serves an informational and transparency function rather than creating compliance obligations.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.